These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 9765754

  • 1. Adjuvant therapy for stage III colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group.
    Figueredo A, Fine S, Maroun J, Walker-Dilks C, Wong S.
    Cancer Prev Control; 1997 Oct; 1(4):304-19. PubMed ID: 9765754
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant therapy for stage II colon cancer after complete resection. Provincial Gastrointestinal Disease Site Group.
    Figueredo A, Germond C, Maroun J, Browman G, Walker-Dilks C, Wong S.
    Cancer Prev Control; 1997 Dec; 1(5):379-92. PubMed ID: 9765760
    [Abstract] [Full Text] [Related]

  • 3. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
    Okawara G, Rusthoven J, Newman T, Findlay B, Evans W.
    Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
    [Abstract] [Full Text] [Related]

  • 4. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
    Logan DM, Lochrin CA, Darling G, Eady A, Newman TE, Evans WK.
    Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
    [Abstract] [Full Text] [Related]

  • 5. Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Provincial Breast Disease Site Group.
    Whelan TJ, Lada BM, Laukkanen E, Perera FE, Shelley WE, Levine MN.
    Cancer Prev Control; 1997 Aug; 1(3):228-40. PubMed ID: 9765748
    [Abstract] [Full Text] [Related]

  • 6. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
    Gill S, Loprinzi CL, Sargent DJ, Thomé SD, Alberts SR, Haller DG, Benedetti J, Francini G, Shepherd LE, Francois Seitz J, Labianca R, Chen W, Cha SS, Heldebrant MP, Goldberg RM.
    J Clin Oncol; 2004 May 15; 22(10):1797-806. PubMed ID: 15067028
    [Abstract] [Full Text] [Related]

  • 7. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
    Poplin EA, Benedetti JK, Estes NC, Haller DG, Mayer RJ, Goldberg RM, Weiss GR, Rivkin SE, Macdonald JS.
    J Clin Oncol; 2005 Mar 20; 23(9):1819-25. PubMed ID: 15774775
    [Abstract] [Full Text] [Related]

  • 8. Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. Provincial Systemic Treatment Disease Site Group.
    Rusthoven J, Bramwell V, Stephenson B.
    Cancer Prev Control; 1998 Aug 20; 2(4):179-90. PubMed ID: 10093631
    [Abstract] [Full Text] [Related]

  • 9. National Surgical Adjuvant Breast and Bowel Project trials in colon cancer.
    Wolmark N, Colangelo L, Wieand S.
    Semin Oncol; 2001 Feb 20; 28(1 Suppl 1):9-13. PubMed ID: 11273592
    [Abstract] [Full Text] [Related]

  • 10. Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma.
    Scheithauer W, Kornek GV, Marczell A, Karner J, Salem G, Greiner R, Burger D, Stöger F, Ritschel J, Kovats E, Vischer HM, Schneeweiss B, Depisch D.
    Br J Cancer; 1998 Apr 20; 77(8):1349-54. PubMed ID: 9579845
    [Abstract] [Full Text] [Related]

  • 11. Fluorouracil plus leucovorin as effective adjuvant chemotherapy in curatively resected stage III colon cancer: results of the trial adjCCA-01.
    Porschen R, Bermann A, Löffler T, Haack G, Rettig K, Anger Y, Strohmeyer G, Arbeitsgemeinschaft Gastrointestinale Onkologie.
    J Clin Oncol; 2001 Mar 15; 19(6):1787-94. PubMed ID: 11251010
    [Abstract] [Full Text] [Related]

  • 12. Levamisole and 5-fluorouracil therapy for resected colon cancer: a new indication.
    Skillings JR, Levine M, Rayner HL, Eisenhauer E, Erlichman C, Germond C, Kerr I, Lofters W, Maroun J, Yoshida S.
    CMAJ; 1991 Feb 01; 144(3):297-301. PubMed ID: 1989708
    [Abstract] [Full Text] [Related]

  • 13. Chemotherapy in stage IV (metastatic) non-small-cell lung cancer. Provincial Lung Disease Site Group.
    Lopez PG, Stewart DJ, Newman TE, Evans WK.
    Cancer Prev Control; 1997 Feb 01; 1(1):18-27. PubMed ID: 9765723
    [Abstract] [Full Text] [Related]

  • 14. Final results of a randomised phase III study on adjuvant chemotherapy with 5 FU and levamisol in colon and rectum cancer stage II and III by the Norwegian Gastrointestinal Cancer Group.
    Dahl O, Fluge Ø, Carlsen E, Wiig JN, Myrvold HE, Vonen B, Podhorny N, Bjerkeset O, Eide TJ, Halvorsen TB, Tveit KM, Norwegian Gastrointestinal Cancer Group.
    Acta Oncol; 2009 Feb 01; 48(3):368-76. PubMed ID: 19242829
    [Abstract] [Full Text] [Related]

  • 15. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.
    Haller DG, Catalano PJ, Macdonald JS, O'Rourke MA, Frontiera MS, Jackson DV, Mayer RJ.
    J Clin Oncol; 2005 Dec 01; 23(34):8671-8. PubMed ID: 16314627
    [Abstract] [Full Text] [Related]

  • 16. Adjuvant systemic chemotherapy for Stage II and III colon cancer after complete resection: an updated practice guideline.
    Jonker DJ, Spithoff K, Maroun J, Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-based Care.
    Clin Oncol (R Coll Radiol); 2011 Jun 01; 23(5):314-22. PubMed ID: 21397476
    [Abstract] [Full Text] [Related]

  • 17. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C, Bury J, Beauduin M, Herman ML, Vindevoghel A, Lecomte M, Brohée D, Canon JL, Focan-Henrard D, GRECCR Belgium.
    Anticancer Res; 2000 Jun 01; 20(6C):4665-72. PubMed ID: 11205198
    [Abstract] [Full Text] [Related]

  • 18. A systematic overview of chemotherapy effects in colorectal cancer.
    Ragnhammar P, Hafström L, Nygren P, Glimelius B, SBU-group. Swedish Council of Technology Assessment in Health Care.
    Acta Oncol; 2001 Jun 01; 40(2-3):282-308. PubMed ID: 11441937
    [Abstract] [Full Text] [Related]

  • 19. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III.
    Taal BG, Van Tinteren H, Zoetmulder FA, NACCP group.
    Br J Cancer; 2001 Nov 16; 85(10):1437-43. PubMed ID: 11720425
    [Abstract] [Full Text] [Related]

  • 20. Clinical overview: adjuvant therapy of gastrointestinal cancer.
    Macdonald JS.
    Cancer Chemother Pharmacol; 2004 Sep 16; 54 Suppl 1():S4-11. PubMed ID: 15309508
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.